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Abstract
John Portz and Peter Eisinger have provided a valuable conceptual overview of state government initiatives for
economic development through biotechnology. Their three major models of policy choice - - based on
interest-group processes, strategic planning, and competing interest groups in the allocation of planned
development initiatives — seem to be sound theoretically and are convincingly examined empirically.
Further, Portz and Eisinger provide a wealth of information regarding comparative state efforts at stimulating
economic innovation, the differing state political dynamics underlying alternative development strategies, and
differences in how such strategies have been implemented. Their analysis represents an important




This article is published as Mack C. Shelley, II, "The States and Biotechnology: Interests, Strategies, and
Dimensions," Politics and the Life Sciences, 9(2), 240-244 (1991) [invited]. doi: 10.1017/
S0730938400010790. Posted with permission.
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/pols_pubs/37
  
The States and Biotechnology: Interests, Strategies, and Dimensions
Author(s): Mack C. Shelley, II
Source: Politics and the Life Sciences, Vol. 9, No. 2 (Feb., 1991), pp. 240-244
Published by: Cambridge University Press
Stable URL: http://www.jstor.org/stable/4235761
Accessed: 25-08-2017 18:28 UTC
 
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide
range of content in a trusted digital archive. We use information technology and tools to increase productivity and
facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.
 
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at
http://about.jstor.org/terms
Cambridge University Press is collaborating with JSTOR to digitize, preserve and extend
access to Politics and the Life Sciences
This content downloaded from 129.186.176.221 on Fri, 25 Aug 2017 18:28:07 UTC
All use subject to http://about.jstor.org/terms
 COMMENTARY
 THE STATES AND BIOTECHNOLOGY: INTERESTS, STRATEGIES, AND
 DIMENSIONS
 Mack C. Shelley, II
 Political Science Department and Statistical Laboratory
 Iowa State Universtity
 Ames, Iowa, 50011
 John Portz and Peter Eisinger have provided a valuable
 conceptual overview of state government initiatives for
 economic development through biotechnology. Their
 three major models of policy choice - - based on interest-
 group processes, strategic planning, and competing inter-
 est groups in the allocation of planned development initia-
 tives ? seem to be sound theoretically and are convinc-
 ingly examined empirically. Further, Portz and Eisinger
 provide a wealth of information regarding comparative
 state efforts at stimulating economic innovation, the differ-
 ing state political dynamics underlying alternative devel-
 opment strategies, and differences in how such strategies
 have been implemented. Their analysis represents an
 important contribution to the current literature on com-
 parative state economic development policy.
 I write from a somewhat differently focused perspective
 than that of Portz and Eisinger. My perspective on biotech-
 nology and its role in economic development has been
 influenced by the key role played by my academic institu-
 tion in large-scale state- and privately-funded research on
 molecular biology, specialized in plant and animal bio-
 technology. That university also has been the home to a
 legislature-mandated interdisciplinary research effort in
 agricultural bioethics. This article turns to a brief summary
 of the recent activity in Iowa relevant to its reliance on
 biotechnology as an engine for economic development.
 This is justifiable on two grounds. First, Iowa is one of the
 states having a substantial political commitment to bio-
 technology research that was omitted from the Portz and
 Eisinger study. Second, the Iowa experience is sufficiently
 distinct to suggest a modification in the Portz-Eisinger tax-
 onomy.
 Briefly, the legislature of Iowa has earmarked over $17
 million in funds from state lottery revenues to support
 research on molecular biology for the express purpose of
 stimulating economic growth and diversifying the state's
 economic base. This effort was stimulated, as in other
 states, by perceived or real declines in traditional sources
 of economic strength as a consequence of international
 competition from the "global economy/* demographic
 shifts and massive out-migration, and the replacement of
 established "smokestack" manufacturing industries with
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 service- oriented and high-technology businesses, among
 other causes. The state, and its political decision-makers,
 were particularly hard hit by the economic transformations
 of the 1980s. Preliminary 1990 census estimates, when
 compared against final 1980 census figures, suggest that
 there was a decline of perhaps 150,000 in the state's
 population during the 1980s. (When the state government
 began seriously to address the link between biotechnology
 and economic development, it was operating with the
 evidence of an estimated net loss of 80,000 people from its
 1980 population base. The demographic shift occasioned
 by economic conditions and quality-of- life considerations
 (see Koven and Shelley, 1989) may have been much worse
 than the political actors had believed when they rather fran-
 tically searched in the mid-1980s for strategies with which
 to combat economic decay and population decline).
 In addition to multimillion-dollar state "seed" funding
 for molecular biology, the state approved construction of
 a new $30.5 million university facility to bring together
 within a single structure several academic laboratories and
 departments active in research on biotechnology. Further,
 a university research park, modelled after many others in
 the nation (such as those at Stanford, the University of
 Michigan, or Boston's Route 128) was initiated, with the
 expectation that firms which had become established
 through a university incubator system would "graduate" to
 the new facility. Some of the firms now located in the
 research park complex have been local leaders in biotech-
 nology research, development, and marketing.
 A series of recent publications (Shelley, Woodman,
 Reichel, and Lasley, 1988; Reichel, Lasley, Woodman,
 and Shelley, 1988; Shelley, Woodman, Reichel, and Kin-
 ney, 1990 (in press)) has examined various aspects of the
 economic and political nexus which links state govern-
 ment, corporations, and universities in cooperative re-
 search relationships. Our findings were based largely on
 surveys which tapped attitudes toward university-industry
 cooperation among biotechnology corporate research di-
 rectors or chief executive officers, state legislators, univer-
 sity administrators, graduate students, farm operators, and
 university faculty involved directly or indirectly with
 biotechnology research and faculty outside that area. Ad-
 ditional work underway in this area of research includes a
 detailed examination of the structural effects on traditional
 academic research and teaching functions from the mas-
 sive financing of new research agendas, and follow-up
 national surveys of biotechnology corporations.
 It is not my purpose to summarize here that set of
 research findings. However, certain commonalities be-
 tween our results and those noted by Portz and Eisinger
 need to be emphasized, as do some topics that are not
 necessarily covered by these two streams of research. In
 light of the signal contribution by Portz and Eisinger to a
 theoretical understanding of the role played by state gov-
 ernments in economic development, this article will con-
 clude with an attempt to incorporate additional informa-
 tion into their taxonomy.
 A key word in the Portz-Eisinger analysis is "entrepre-
 neurial." Universities and state governments long have
 been engaged in entrepreneurial activities, as part of an
 endless search for "outside" funding for research and
 economic activities. With biotechnology as an exemplar
 of this process, such efforts at entrepreneurship have
 become far more pronounced since the late 1970s. For
 state governments, the need to redress the disruptions
 produced by economic adjustment and regional economic
 decline during the 1980s resulted in a common tendency to
 try to "kick- start" faltering sectors of the economy by
 facilitating private investment in new areas of industry and
 services, and by providing financial inducements and start-
 up funds for cooperative research between academe and
 corporations.
 For universities, the promise of enhanced funding for
 both traditional and completely new areas of research,
 including the hiring of new faculty, the development of
 new programs and departments, and the acquisition of new
 equipment and graduate assistants, was mingled with pres-
 sure from corporate donors and often from state decision
 makers and internal groups to provide an almost irresist-
 ible allure. This condition was in large part a consequence
 of reduced federal government support for research and for
 state-level programs generally. This reduction was in turn
 a concomitant of the world-wide retrenchment from ag-
 gressive positive central government activity aimed at fos-
 tering greater economic equality and full employment. A
 near-mania for privatization, the presumed innate superi-
 ority of capitalist management over government direction,
 and a sauve-qui-peut attitude on the part of politically-
 influential corporate leaders combined with constituent
 pressures demanding that the dislocations from the emerg-
 ing world economy be redressed, to drive state government
 sponsorship of the promise of entrepreneurial effort.
 One of the central research issues posed by Portz and
 Eisinger is how state policymakers make policy choices
 regarding which scientific endeavors to support, in the
 absence of scientific expertise of their own and given an
 imprecise set of contextual and political constraints. Among
 our survey groups was the membership of both chambers
 of the Iowa legislature, of whom about one-half responded
 to a mailed questionnaire addressing almost precisely
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 these concerns. Although the Iowa legislature is not iden-
 tical to those of other states in decision making dynamics,
 the role of partisanship, relationships with the state execu-
 tive branch, and the like, the response of these key political
 actors likely was conditioned by events and perceptions
 similar to those operating in most other states which have
 made a strong commitment of state funds and legitimacy to
 the economic development effort. What we found, then, is
 of fairly broad generalizability to state responses to stimu-
 late economic development through support of biotech-
 nology.
 Among our clearest findings from our survey of state
 legislators was their uncertainty about whether this com-
 mitment would pay economic dividends. Overall, the
 attitudes of state legislators on many issues related to bio-
 technology did not differ sharply from the views held by
 members of academic respondent groups. However, a
 sharp distinction existed between the attitudes of the legis-
 lators and the views held by farm operators, a major con-
 stituency group of many of the responding legislators. The
 farm operators felt, or hoped, that biotechnology would,
 among other benefits, resolve farm surplus problems,
 provide scale-neutral benefits to farm operations of any
 size, and produce new profitable animal and plant varie-
 ties, whereas the state legislators had far less sanguine
 expectations of the revolution in molecular biology.
 Portz and Eisinger address the complex topic of technol-
 ogy transfer, or the transition from research to successful
 commercialization. A missing item in their discussion,
 though, is the burgeoning links between universities and
 industries, which often take place with government sup-
 port and encouragement. A particularly important aspect
 of the recent expansion of university-industry research
 relationships is the symbiosis implied by the growth of
 research parks, business incubator facilities, and special-
 ized research centers, which often are located in university
 facilities. Research parks are a particularly concrete mani-
 festation of the closer links that have been forged between
 corporate interests and the goals of academe.
 In our own study of this phenomenon (Shelley, Woodman,
 Reichel, and Lasley, 1990), it is apparent that there are
 certain differences of opinion as to the goals of that
 particular form of university-industry research nexus. For
 example, biotechnology corporations are anxious to retain
 control over patent and marketing rights, whereas univer-
 sity and state legislative respondents tend to be more open
 to sharing both research effort and output. It is noteworthy
 in this regard that a recent series of national reports (e.g.,
 Academe, 1990) has emphasized the difficulties encoun-
 tered by some of the university-based research parks, and
 has discussed the advantages and risks of university-
 industry research relationships.
 Portz and Eisinger report briefly on a number of political
 and social issues revolving around state economic devel-
 opment efforts in biotechnology. While space constraints
 prevent a full discussion here of these matters, it is impor-
 tant to emphasize that further research in these areas is
 essential in order for a fuller social science perspective on
 biotechnology to develop. One such issue is that of the
 regulation of biotechnology, with attendant political im-
 plications such as anomic environmental activism, more
 organized Greens'-style political pressure both through
 demonstrations and at the ballot box, and mass public con-
 cern over the impacts of the experimental release of geneti-
 cally-altered organisms.
 Particular concern during the 1980s, and in fact at least
 since the Asilomar conference which imposed a temporary
 ban on genetic engineering work, has centered on the fear
 that potentially harmful genetically altered plant or animal
 organisms would escape from experimental studies and
 spread uncontrolled though the biosphere. Further public
 opinion research in this area of policy concern should be
 undertaken, perhaps along the lines of the national mass
 survey conducted by the Office of Technology Assess-
 ment. Additional work should be done on developing a
 systematic understanding of the responses of state govern-
 ment to meet such public concerns, particularly as mani-
 fested in state-level regulatory agencies and relevant con-
 trolling legislative statutes and executive orders. It would
 be particularly enlightening, as a case study in intergovern-
 mental relations, to see to what extent the state regulatory
 efforts may mimic those of the federal government, such as
 the recombinant DNA advisory committee (RAC) at the
 National Institutes of Health or the umbrella Biological
 Sciences Coordinating Committee, as well as the adapta-
 tion of traditional mechanisms (such as the "generally rec-
 ognized as safe" ? GRAS ?standards).
 Other major political and social considerations have
 arisen in regard to biotechnology. Sustainable agriculture
 is of paramount concern to many of those who conduct
 research in agricultural biotechnology. Although difficult
 to define, sustainable agriculture clearly is linked to ques-
 tions surrounding biotechnology. Will genetically-altered
 farm organisms, whether plant or animal, provide equal
 benefits for small-scale "family" farmers and for larger
 operations? Most research on the diffusion of technologi-
 cal innovations would suggest that the likely benefits
 would accrue disproportionately to larger-scale opera-
 tions. Would biotechnology produce increased farm sur-
 pluses, thereby making more farm operators economically
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 marginal and driving down farm commodity prices? This
 is precisely the question that has come to the political
 forefront in states such as Wisconsin, in which the legisla-
 ture recently enacted a ban on the use of genetically-
 engineered bovine growth hormone following strong po-
 litical pressure from dairy farmers and from environmental
 interests that felt threatened by the new technology. More
 work on the interest group dynamics of the reaction to bio-
 technology must be done.
 Animal rights provides another area of rising concern
 with potentially major political implications. Radical anti-
 animal experimentation groups have been active in Great
 Britain and other countries for some time, and their tactics
 are being adopted by some of the more aggressive animal
 rights groups in the United States. Problems such as those
 experienced by arthritic-kneed "geeps" (chimeric animals
 that are hybrids of goats and sheep) or the extremely
 cramped conditions under which animal production agri-
 culture often takes place are amplified by the concerns of
 activist groups over the use of animals in laboratory
 experimentation (in biotechnology and otherwise) and in
 the commercial production of skins and furs. How state
 governments will address these potentially explosive prob-
 lems remains to be studied.
 Controversy over the human genome project, which
 promises to absorb a billion dollars of federal research
 funds in the effort to map the complex structures of the
 human genetic code, reveals yet another aspect to biotech-
 nology. To the extent that key sectors of the mass public
 or of decision-making elites see potential advantages or
 threats to human health and welfare, and indeed to human
 evolution and to our survival as a species from the pros-
 pects of fundamentally altering the human genetic code,
 national and state government attention inevitably will be
 turned to the implications of this research. Here, there is
 strong potential that religious sentiments, as well as other
 moral philosophies of what it means to be human and how
 people ought to be defined and treated, are likely to enter
 into the political fray in major ways. Whether state
 governments will be able to address such matters success-
 fully remains to be seen. The gingerly way in which many
 state governments have approached the abortion issue
 suggests perhaps that human genome research will pro-
 duce equivocation from decision makers for as long as
 public opinion makes that reaction possible, to be followed
 by intensive lobbying by activist groups on either side of
 the controversy and partial solutions to the attendant legal,
 political, social, and economic issues which will accom-
 pany such a fundamental approach to human nature and
 human welfare.
 Portz and Eisinger have provided a real service to the
 study of the political dimensions of biotechnology. Per-
 haps the real test of their models, and therefore of their
 theoretical conceptualization, lies in the ability of their
 taxonomy to incorporate new information. My reading of
 the Iowa situation regarding biotechnology and economic
 development is that that state's experience would fit best
 with Portz and Eisinger's hybrid model. However, the
 Iowa experience does not fit very comfortably into that
 framework, both because the planning exercise was stra-
 tegic only in name, and because interest-group activity was
 limited to only a few actors. This consideration leads to the
 following proposal for a reconsideration of the Portz and
 Eisinger typology. Such a typology would, for one thing,
 have to address the redistributive, as well as the distribu-
 tive and regulatory dimensions (to borrow from Lowi) of
 state actions to foster economic development, many of
 which may be simply another form of "trickle-down" eco-
 nomics which provides lots of money for businesses and
 entrepreneurs but which produces little payoff in jobs for
 new workers or for the less privileged segments of the
 established work force. The Iowa experience in particular
 has been characterized by widespread concern over the
 scale-neutrality of biotechnology, a concern that was deep-
 ened by the decline of family-scale farm operations during
 the 1980s and a perceived growth of agribusiness-run
 farms.
 Also, the role and the extent of interest aggregation in the
 political deliberations that take place regarding biotech-
 nology- driven interventions in the state's economy needs
 to be clarified. Whether this is an open process, with fairly
 well-thought out planning of the consequences of this
 development focus, will determine which actors, including
 the mass public, benefit from the decisions that are made.
 This consideration, for example, is related to implications
 for university teaching and research, worker health and
 safety, environmental protection, differential benefits for
 various sectors of the state economy, whether targets for
 new jobs creation are met, and the allocation of symbolic,
 as opposed to material, benefits. In other words, the
 emphasis perhaps should be more on differential policy
 outputs and less on the different processes by which states
 have made biotechnology a major focus of their economic
 development efforts.
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